The U.S. Food and Drug Administration gave De Novo clearance to Techsomed's BioTraceIO, which leverages a computational algorithm to analyze ultrasound images captured during liver ablation treatment ...
Hepatocellular carcinoma (HCC) management is rapidly evolving as systemic therapies and locoregional treatments are increasingly combined across disease ...
Microwave ablation (MWA) of colorectal liver metastases (CRLM) had low rates of failure and morbidity and warrants consideration as definitive treatment, authors of a large clinical review suggested.
REHOVOT, Israel , Jan. 8, 2024 /PRNewswire/ -- Techsomed Medical Technologies LTD is thrilled to announce that FDA has granted De Novo clearance for its BioTraceIO, a groundbreaking ultrasound-based ...
Thermal ablation demonstrated noninferiority to surgical resection for small colorectal liver metastases, with comparable overall survival and local control outcomes. The COLLISION trial showed ...
Multicentre data show microwave ablation offers comparable survival to repeat liver resection for first recurrent ...
Treatment options for liver cancer vary based on the cancer stage and a person’s overall health and liver function. A person should work with their treatment team to determine the best treatment ...
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver tumors return quickly after thermal ablation, a widely used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results